Approval · Notice of Compliance 34404 · 2024
VANIQA: Notice of Compliance 34404
Issued November 19, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34404
- Date
- November 19, 2024
- Company
- Cipher Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site and/or manufacturer involving production of the starting material
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VANIQA | Not yet assigned | — |
Medicinal ingredients
- EFLORNITHINE HYDROCHLORIDE 13.9 PER